kabutan

TAIKO PHARMA, 71% Decrease in Ordinary Profit for The Current Fiscal Year

Thu Feb 13, 2025 3:30 pm JST Earnings

4574 TAIKO PHARMACEUTICAL CO., LTD. 【J-GAAP】

Earnings Report

TAIKO PHARMACEUTICAL CO., LTD. <4574> [TSE Prime] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit/loss for the fiscal year ending December 2024 turned into a profit of 0.68 billion yen (compared to a loss of 1.24 billion yen in the previous period). In the fiscal year ending December 2025 is also bleak, with an expected significant drop by 70.9% from the previous period to 0.2 billion yen.

At the same time, the company has decided to forego the previously undecided year-end lump-sum dividend, and has left the annual dividend for the current term undetermined.

In the most recent three-month period, from October to December (4Q), the consolidated ordinary loss improved to a deficit of 0.01 billion yen (compared to a loss of 0.65 billion yen in the same period last year). The operating profit/loss margin drastically improved from -32.9% in the same period last year to -5.7%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 5,040 -3,079 -3,352 -4,895 -112.3 0 Feb 10, 2023 J-GAAP
Dec, 2023 6,120 -1,005 -1,248 -3,611 -76.3 0 Feb 9, 2024 J-GAAP
Dec, 2024 6,292 629 688 898 17.9 0 Feb 13, 2025 J-GAAP
YoY +2.8% － － － －

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance 6,800 550 590 550 11.0 － Aug 9, 2024 J-GAAP
Dec, 2024 Results 6,292 629 688 898 17.9 0 Feb 13, 2025 J-GAAP
Revision Rate -7.5% +14.4% +16.6% +63.3% +63.3%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 2,860 482 528 764 15.2 0 Aug 9, 2024 J-GAAP
Jan - Jun, 2025 Guidance ー ー ー ー － － Feb 13, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 6,120 -1,005 -1,248 -3,611 -76.3 0 Feb 9, 2024 J-GAAP
Dec, 2024 6,292 629 688 898 17.9 0 Feb 13, 2025 J-GAAP
Dec, 2025 Guidance 6,300 215 200 300 6.0 － Feb 13, 2025 J-GAAP
YoY +0.1% -65.8% -70.9% -66.6% -66.6%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 1,703 -561 -659 -3,049 -64.4 -32.9 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 1,377 214 229 472 9.4 15.5 May 10, 2024 J-GAAP
Apr - Jun, 2024 1,483 268 299 292 5.8 18.1 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 1,719 244 177 -50 -1.0 14.2 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 1,713 -97 -17 184 3.7 -5.7 Feb 13, 2025 J-GAAP
YoY +0.6% +82.7% +97.4% － －

Related Articles